Immune System Diseases: all 288 studies
Page 1 of 3. Open to participants first (80), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseaseRecruitingNCT07885605Phase 1
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruitingNCT07783425Phase 3
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingNCT07765888Phase 3
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyRecruitingNCT07759115Not applicable
- A Study of HL40626S Tablets in Healthy AdultsNot yet recruitingNCT07736586Phase 1
- Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT07734415Phase 2
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)RecruitingNCT07699380Phase 2
- Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal InfectionNot yet recruitingNCT07672496Not applicable
- Project PHOENIX: Molecular Signatures of Burn Pit ExposureNot yet recruitingNCT07562243
- A Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruitingNCT07541287Phase 2
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaRecruitingNCT07192471Phase 1
- PS-002 for the Treatment of IgA Nephropathy in AdultsRecruitingNCT07182227Phase 1/2
- A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaRecruitingNCT07075185Phase 1
- Natural History of Type 1 Interferonopathies: Insights From a European CohortRecruitingNCT07040774
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07037901Phase 2
- Atacicept in Multiple Glomerular DiseasesRecruitingNCT06983028Phase 2
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
- Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.RecruitingNCT06858319Phase 3
- CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System DiseasesRecruitingNCT06787560Early Phase 1
- Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Management of Pediatric and Adult Patients with Immune System DisordersRecruitingNCT06773546
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- US Zamto-cel Autoimmune DiseasesRecruitingNCT06708845Phase 1
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 2
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruitingNCT06575426Phase 1/2
- Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRURecruitingNCT06551389
- The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal CancerEnrolling by invitationNCT06540027
- Digital Diagnostics and Intervention Services for Parkinson's DiseaseNot yet recruitingNCT06534177
- Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus ErythematosusEnrolling by invitationNCT06475742Phase 3
- Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID RegistryRecruitingNCT06417502
- Cross-condition Validation of the Steroid PRORecruitingNCT06314451
- A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL StudyRecruitingNCT06271252Phase 1
- Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological DysfunctionsRecruitingNCT06235580
- Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of ImmunityRecruitingNCT06169150
- Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19Not yet recruitingNCT06142279Not applicable
- Aerobic Training and Diet Protocol on Immune System in Burn Patients.RecruitingNCT06141915Not applicable
- Epigenetic Memory of Vitamin D SupplementationRecruitingNCT06104111Phase 1
- Implementation of Support in the Care of Adults Living With Type 1 DiabetesRecruitingNCT06069583Not applicable
- Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and PolymorphismsRecruitingNCT06065592Phase 1
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
- Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLRecruitingNCT05963217Phase 1
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaRecruitingNCT05826535Phase 1/2
- Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic DiseasesRecruitingNCT05807256
- A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory ConditionRecruitingNCT05787574Phase 2
- Patients Pregnant Women With or Without Primary Antiphospholipid Antibody SyndromeRecruitingNCT05786235
- Prospective Observational Study to Characterize Patients Treated at Internal Medicine ClinicsRecruitingNCT05780099
- Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaRecruitingNCT05726461Not applicable
- Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPDRecruitingNCT05507242Phase 2
- Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to GenotypeRecruitingNCT05425953
- Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)RecruitingNCT05418010Phase 2
- Association of Silicone Breast Implants With Overall Wellbeingand Auto-immune DiseasesEnrolling by invitationNCT05400954
- A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)Enrolling by invitationNCT05352919Phase 3
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable
- Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related DiseasesRecruitingNCT05318196
- Preterm Immune System Development and Response to ImmunizationRecruitingNCT05266664
- Study of Gastric Motility in Eosinophilic GastritisRecruitingNCT05229432
- Montreal Immune-Related Adverse Events (MIRAE) StudyRecruitingNCT05139706
- PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and ImmunityRecruitingNCT05002023
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 2
- Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO StudyEnrolling by invitationNCT04996706
- Biologics And Clinical Immunology Cohort at SinaiRecruitingNCT04784364
- A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A NephropathyRecruitingNCT04663204Phase 2
- Evolution of Metabolic and Immune Dysfunction in In-transit MelanomaRecruitingNCT04658303
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 3
- Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)Not yet recruitingNCT04430972
- A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)RecruitingNCT04422912Phase 1/2
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of ImmunityRecruitingNCT04339777Phase 2
- Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side EffectsRecruitingNCT04242095
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasRecruitingNCT04104776Phase 1/2
- Thinking Zinc: a Study of Zinc Supplements on the Navajo NationRecruitingNCT03908736Phase 2
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)RecruitingNCT03328078Phase 1/2
- Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersRecruitingNCT03207854
- Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant DisordersRecruitingNCT03128996Phase 1/2
- Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesRecruitingNCT02579967Phase 2
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)RecruitingNCT01568697
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruitingNCT00794352
- Detection and Characterization of Infections and Infection SusceptibilityRecruitingNCT00404560
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)RecruitingNCT00006150
- Genetic Analysis of Immune DisordersRecruitingNCT00001467
- Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
- Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
- Individualizing Treatment for Asthma in Primary CareCompletedNCT06272370Phase 4Results posted
- HIV Engagement and Adolescent Depression Support (HEADS-UP)CompletedNCT06173544Not applicableResults posted
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata ParticipantsCompletedNCT06060977Phase 1/2Results posted
- A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
- A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)TerminatedNCT05984784Phase 1/2Results posted
- A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisTerminatedNCT05516758Phase 2Results posted
- A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.CompletedNCT05228470Phase 2Results posted
- A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsActive, not recruitingNCT05217641Phase 1Results posted
- ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedNCT04835441Phase 2Results posted
- Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in VietnamCompletedNCT04790201Not applicableResults posted
- Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
- Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney TransplantationTerminatedNCT04294459Phase 1/2Results posted
- Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2Results posted
- Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsCompletedNCT04071405Results posted
- A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)CompletedNCT03744676Phase 2Results posted
- Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
- Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell LymphomaActive, not recruitingNCT03696784Phase 1Results posted
- Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingNCT03663933Phase 2Results posted